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Response:
Schuchlenz1 makes important observations that help frame the 
conclusions we reached through analysis of the transesophageal 
echocardiography data from the Risk of Paradoxical Embolism 
(RoPE) database and appropriately highlights some of the limitations 
of this data set. Specifically, important anatomic features (presence or 
absence of a prominent eustachian valve) were not routinely reported 
across the component databases. Additionally, microbubbles were 
routinely injected via the antecubital vein, a site that Schuchlenz1 cor-
rectly identifies as correlating less well with anatomic size.
To create our RoPE database,2 component studies were combined 
and data were harmonized with the goals of improving on the meth-
odological and statistical limitations of small individual studies. 
Yet harmonization across databases creates its own challenges and 
necessarily excludes details that might not be uniformly collected 
across component studies, including some transesophageal echocar-
diography variables. Our observation that proposed that high-risk 
transesophageal echocardiography features do not correlate with the 
significance of an observed patent foramen ovale for patients with 
cryptogenic stroke3 should be viewed not as a failure of the imaging 
modality as ideally applied. Instead, we view it as a call for further 
refining the technique, improving standardization and conducting fur-
ther research, and as a call too for development of complimentary 
techniques to better assess risk.
Sources of Funding
This study was partially funded by grants UL1 RR025752, R01 
NS062153, and R21 NS079826 from the National Institutes of Health.
Disclosures
Drs Kent and Thaler have consulted for WL Gore Associates. Dr 
Thaler is a consultant to AGA Medical Corporation. The other au-
thors report no conflicts.
Benjamin S. Wessler, MD
Division of Cardiology, Tufts Medical Center
Boston, MA 
David E. Thaler, MD, PhD
Department of Neurology, Tufts Medical Center/Tufts University 
School of Medicine
Boston, MA 
Robin Ruthazer, MPH
Predictive Analytics and Comparative Effectiveness Center 
Institute for Clinical Research and Health Policy Studies, Tufts 
Medical Center/Tufts University School of Medicine
Boston, MA 
Christian Weimar, MD
Department of Neurology, University of Duisburg-Essen
Essen, Germany 
Marco R. Di Tullio, MD
Division of Cardiology, Columbia University
New York, NY 
Mitchell S. V. Elkind, MD, MS
Departments of Neurology and Epidemiology, Columbia University
New York, NY 
Shunichi Homma, MD
Division of Cardiology, Columbia University
New York, NY 
Jennifer S. Lutz, MS
Predictive Analytics and Comparative Effectiveness Center 
Institute for Clinical Research and Health Policy Studies, Tufts 
Medical Center/Tufts University School of Medicine
Boston, MA 
Jean-Louis Mas, MD
Department of Neurology, Hôpital Sainte-Anne, Paris-Descartes 
University
Paris, France 
Heinrich P. Mattle, MD
Department of Neurology, Inselspital, University of Bern
Bern, Switzerland 
Bernhard Meier, MD
Department of Cardiology, Swiss Cardiovascular Center, 
Inselspital, University of Bern
Bern, Switzerland 
Krassen Nedeltchev, MD
Department of Neurology, Triemli Municipal Hospital
Zürich, Switzerland 
Federica Papetti, MD
Department of Cardiology, University of Rome La Sapienza
Rome, Italy 
Emanuele Di Angelantonio, MD, MSc, PhD
Department of Public Health and Primary Care, University of 
Cambridge
Cambridge, United Kingdom 
Mark Reisman, MD
Cardiology Clinic, University of Washington
Seattle 
Joaquín Serena, MD, PhD
Department of Neurology, Hospital Universitari Doctor Josep 
Trueta Institut d’Investigació Biomèdica de Girona
Girona, Spain 
David M. Kent, MD, CM, MSc
Predictive Analytics and Comparative Effectiveness Center 
Institute for Clinical Research and Health Policy Studies 
Tufts Medical Center/Tufts University School of Medicine
Boston, MA 
References
 1. Schuchlenz H. Letter by Schuchlenz Regarding Article, “Transesophageal 
echocardiography in cryptogenic stroke and patent foramen ovale: analy-
sis of putative high-risk features from the risk of paradoxical embolism 
database.” Circ Cardiovasc Imaging. 2014;7:572.
 2. Thaler DE, Di Angelantonio E, Di Tullio MR, Donovan JS, Griffith 
J, Homma S, Jaigobin C, Mas JL, Mattle HP, Michel P, Mono ML, 
Nedeltchev K, Papetti F, Ruthazer R, Serena J, Weimar C, Elkind MS, 
Kent DM. The risk of paradoxical embolism (RoPE) study: initial de-
scription of the completed database. Int J Stroke. 2013;8:612–619.
 3. Wessler BS, Thaler DE, Ruthazer R, Weimar C, Di Tullio MR, Elkind 
MS, Homma S, Lutz JS, Mas JL, Mattle HP, Meier B, Nedeltchev 
K, Papetti F, Di Angelantonio E, Reisman M, Serena J, Kent DM. 
Transesophageal echocardiography in cryptogenic stroke and patent fo-
ramen ovale: analysis of putative high-risk features from the risk of para-
doxical embolism database. Circ Cardiovasc Imaging. 2014;7:125–131.
(Circ Cardiovasc Imaging. 2014;7:573.)
© 2014 American Heart Association, Inc.
Circ Cardiovasc Imaging is available at http://circimaging.ahajournals.org DOI: 10.1161/CIRCIMAGING.114.001756
Response to Letter Regarding Article, 
“Transesophageal Echocardiography in 
Cryptogenic Stroke and Patent Foramen Ovale 
Analysis of Putative High-Risk Features From the 
Risk of Paradoxical Embolism Database”
Correspondence
 at Universitaetsbibliothek Bern on February 12, 2015http://circimaging.ahajournals.org/Downloaded from 
s
o
u
r
c
e
:
 
ht
tp
:/
/b
or
is
.u
ni
be
.c
h/
63
20
5/
 
| 
do
wn
lo
ad
ed
: 
16
.2
.2
01
5
Reisman, Joaquín Serena and David M. Kent
Bernhard Meier, Krassen Nedeltchev, Federica Papetti, Emanuele Di Angelantonio, Mark
Mitchell S. V. Elkind, Shunichi Homma, Jennifer S. Lutz, Jean-Louis Mas, Heinrich P. Mattle, 
Benjamin S. Wessler, David E. Thaler, Robin Ruthazer, Christian Weimar, Marco R. Di Tullio,
From the Risk of Paradoxical Embolism Database''
Cryptogenic Stroke and Patent Foramen Ovale Analysis of Putative High-Risk Features 
Response to Letter Regarding Article, ''Transesophageal Echocardiography in
Print ISSN: 1941-9651. Online ISSN: 1942-0080 
Copyright © 2014 American Heart Association, Inc. All rights reserved.
Dallas, TX 75231
is published by the American Heart Association, 7272 Greenville Avenue,Circulation: Cardiovascular Imaging 
doi: 10.1161/CIRCIMAGING.114.001756
2014;7:573Circ Cardiovasc Imaging. 
 http://circimaging.ahajournals.org/content/7/3/573
World Wide Web at: 
The online version of this article, along with updated information and services, is located on the
  
 http://circimaging.ahajournals.org//subscriptions/
is online at: Circulation: Cardiovascular Imaging  Information about subscribing to Subscriptions:
  
 http://www.lww.com/reprints
 Information about reprints can be found online at: Reprints:
  
document. Permissions and Rights Question and Answer information about this process is available in the
requested is located, click Request Permissions in the middle column of the Web page under Services. Further
Center, not the Editorial Office. Once the online version of the published article for which permission is being 
 can be obtained via RightsLink, a service of the Copyright ClearanceCirculation: Cardiovascular Imagingin
 Requests for permissions to reproduce figures, tables, or portions of articles originally publishedPermissions:
 at Universitaetsbibliothek Bern on February 12, 2015http://circimaging.ahajournals.org/Downloaded from 
